Current:Home > StocksAfter US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen-Angel Dreamer Wealth Society D1 Reviews & Insights
After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
View Date:2024-12-23 17:01:11
TOKYO (AP) — Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies. It’s the first drug for treatment of the disease in a country with a rapidly aging population.
Developed by Japanese drugmaker Eisai Co. and U.S. biotechnology firm Biogen Inc., the drug’s approval in Japan comes two months after it was endorsed by the U.S. Food and Drug Administration.
Leqembi is for patients with mild dementia and other symptoms in the early stages of Alzheimer’s disease, and the first medicine that can modestly slow their cognitive decline.
Prime Minister Fumio Kishida, who announced Japan’s approval of Leqembi on Monday, called it “a breakthrough” and said that the “treatment of dementia has now entered a new era.”
Kishida has pledged to step up support for the growing number of dementia patients and their families and is due to launch a panel this week to discuss measures for a dementia-friendly society.
According to the health ministry, Japan’s number of dementia patients who are 65 years of age or older will rise to 7 million in 2025, from the current 6 million.
The drug, however, does not work for everyone and — as with other Alzheimer’s drugs that target plaques in the brain — can cause dangerous side effects such as brain swelling and bleeding in rare cases.
Eisai said it will conduct a post-marketing special use survey in all patients administered the drug until enough data is collected from unspecified number of patients under Japanese health ministry procedures.
The drug will be partially covered by health insurance and is expected to be ready for clinical use by the end of the year. The price is yet to be decided but is expected to be expensive, Kyodo News agency reported.
Eisai is committed to delivering Leqembi to people who need it and their families “as a new treatment,” said Haruo Naito, the company’s CEO.
“We aim to create impact on issues surrounding dementia in Japanese society,” he said.
veryGood! (64443)
Related
- New Mexico secretary of state says she’s experiencing harassment after the election
- Las Vegas, Miami, New Orleans? Which city was just named most fun in the United States.
- A roadside bombing in the commercial center of Pakistan’s Peshawar city wounds at least 3 people
- Dolphins' Tua Tagovailoa reveals strategy on long TD passes to blazing fast Tyreek Hill
- Chris Wallace will leave CNN 3 years after defecting from 'Fox News Sunday'
- If you like the ManningCast, you'll probably love the double dose ESPN plans to serve up
- Mexico halts deportations and migrant transfers citing lack of funds
- Sen. Krawiec and Rep. Gill won’t seek reelection to the North Carolina General Assembly
- Florida Man Arrested for Cold Case Double Murder Almost 50 Years Later
- Video shows elderly 17-year-old Shih Tzu rescued from air vent in Virginia home: Watch
Ranking
- Why Dolly Parton Is a Fan of Taylor Swift and Travis Kelce's Little Love Affair
- YouTuber who staged California plane crash gets 6 months in prison for obstructing investigation
- Owners of a funeral home where 190 decaying bodies were found to appear in court
- Tom Holland Shares What He Appreciates About Girlfriend Zendaya
- QTM Community Introduce
- Fossil fuels influence and other takeaways from Monday’s climate conference events
- Detroit-area performing arts center reopens after body is removed from vent system
- When is New Year's day? Here's when the holiday falls for 2024 and why we celebrate it.
Recommendation
-
New Mexico secretary of state says she’s experiencing harassment after the election
-
Academy Museum Gala: Leonardo DiCaprio, Salma Hayek, Selena Gomez, more shine on red carpet
-
Move over, Mariah. Brenda Lee's 'Rockin' Around the Christmas Tree' is No. 1
-
Virginia officials certify 2023 legislative election results, other electoral contests
-
Olympic Skier Lindsey Vonn Coming Out of Retirement at 40
-
Remains found in Indiana in 1982 identified as those of Wisconsin woman who vanished at age 20
-
Philadelphia Eagles bolster defense, sign 3-time All-Pro LB Shaquille Leonard to 1-year deal
-
Suzanne Somers’ Husband Shares the Touching Reason She’s Laid to Rest in Timberland Boots